Clinical Trial Of Homoeopathic Genus Epidemicus 'Arsenic Alba' As A Prophylactic During Pandemic Of Covid 19 In India At Dr. V. H. Dave Homoeopathic Medical Collage

Clinical Trial Of Homoeopathic Genus Epidemicus 'Arsenic Alba' As A Prophylactic During - Covid 19

Abstract

Background: The objective was to assess the usefulness of Homoeopathic genus epidemics (Arsenic alba 30C) for the prevention of Covid 19 during its pandemic outbreak in the state of Gujrat District Anand, City Anand, India. Materials and Methods: A non- randomized, clinical trial was conducted in Anand city for prevention of Covid 19 during the pandemic outbreak in June 2020 to December 2020. Arsenic alba 30C was randomly administered to 1133 participants. Healthy participants (absence of fever, runny nose, cough etc., but comorbidity like DM & HTN included) were eligible for the study (Arsenic alba 30 C n =1133). Monthly follow-up was done for 6 months. Infection rate in the study groups was analyzed and compared by use of cluster analysis. Results: The findings showed that only 4 persons out of 1133 persons of Arsenic alba 30 C group suffered from Covid 19. Cluster analysis showed significant prevention during Pandemic without any vaccine or other medications. [Incidence rate = 0.35%]. Conclusion: Arsenic alba 30C as genus epidemics is much better in decreasing the incidence of Covid 19 in cluster in Anand. The efficacy of genus epidemicus needs to be replicated in different areas. [Dhighe L Natl J Integr Res Med, 2021; 12(4): 62-65]